Loading
Yanuki
ARTICLE DETAIL
Blackstone and TPG Eye Hologic Acquisition: A Potential $16B Deal | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Micron Stock: Supply Tightness and Growth Potential in 2026 | Blackstone and TPG Eye Hologic Acquisition: A Potential $16B Deal | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Micron Stock: Supply Tightness and Growth Potential in 2026

Finance / Investment

Blackstone and TPG Eye Hologic Acquisition: A Potential $16B Deal

Private equity firms Blackstone (BX) and TPG have jointly expressed interest in acquiring healthcare company Hologic (HOLX) in a deal potentially worth over $16 billion. While Hologic initially turned down the offer, speculation remains abo...

TPG and Blackstone offered $16bn to take health group Hologic private
Share
X LinkedIn

hologic
Blackstone and TPG Eye Hologic Acquisition: A Potential $16B Deal Image via Financial Times

Key Insights

  • **Initial Offer:** Blackstone and TPG proposed a deal valuing Hologic between $70 and $72 per share, totaling $16.3 to $16.7 billion including debt.
  • **Market Reaction:** Following the report, Hologic’s shares jumped by 7% to $58.21.
  • **Analyst Sentiment:** The average one-year price target for Blackstone Inc. is $151.86, suggesting a potential upside of 9.29%.
  • **GF Value:** GuruFocus estimates Blackstone’s fair value at $199.87, indicating a possible upside of 43.84%.
  • **Blackstone’s Performance:** Blackstone reported strong Q1 results with distributable earnings up 11% year-over-year to $1.4 billion and AUM increased 10% year-over-year to nearly $1.2 trillion.

In-Depth Analysis

### Background The Financial Times reported that Blackstone and TPG approached Hologic with a buyout offer, leading to an immediate surge in Hologic’s stock price. The offer, though initially rejected, has sparked discussions about the future of Hologic and potential strategic shifts.

### Market Reaction and Analyst Views Hologic’s stock experienced a notable increase following the news, reflecting investor optimism about the potential deal. Analysts have provided varied price targets for Blackstone, with an average target suggesting moderate upside. GuruFocus’s GF Value indicates a more substantial potential upside for Blackstone, based on historical multiples and future performance estimates.

### Blackstone’s Financial Health Blackstone’s recent financial results highlight its strong position in the market. Key metrics from Q1 2025 include: - Distributable Earnings: $1.4 billion - Assets Under Management (AUM): Nearly $1.2 trillion - Inflows: $62 billion

These figures underscore Blackstone’s robust financial health and its capacity to undertake significant acquisitions.

### Potential Challenges Despite positive indicators, uncertainty around tariffs and market volatility could affect investor sentiment and realization activity. The IPO market also remains challenging, which may impact potential exits.

Read source article

FAQ

- **Q: What was the initial offer for Hologic?

**

- **Q: How did Hologic’s stock react to the news?

**

- **Q: What is the average analyst price target for Blackstone?

**

- **Q: What are some of Blackstone’s key financial results from Q1 2025?

**

Takeaways

  • Monitor Hologic (HOLX) stock for further movements as negotiations progress.
  • Keep an eye on Blackstone’s (BX) performance, considering analyst price targets and GF Value estimates.
  • Be aware of potential market volatility and its impact on investment decisions.
  • Understand that while the acquisition could offer significant upside, challenges such as tariffs and IPO market conditions could pose risks.

Discussion

Do you think this acquisition will proceed? What impact would it have on the healthcare sector? Share your thoughts in the comments below!

Share this article with others who need to stay ahead of this trend!

Sources

Disclaimer

This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.

All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.

This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.

Always do your own research (DYOR) before making any decisions based on the information presented.